Corrigendum to “12P The efficacy of EGFR tyrosine kinase inhibitors and its clinical prognostic factors in lung adenocarcinoma patients harboring different types of EGFR mutations: Real-world data”
R. Vicente, Matheus Callak Teixeira Vitorino, R. Ferreira, Ana Vitória Magalhães Chaves
0 citationsAnnals of Oncology